Open AccessResibufogenin inhibits the malignant characteristics of multiple myeloma cells by blocking the PI3K/Akt signaling pathway
Author(s) -
Yan Zhou,
Zirui Hong,
Keting Jin,
Chenjun Lin,
Jingjing Xiang,
Hangping Ge,
Zhi Zheng,
Jianping Shen,
Shu Deng
Publication year - 2022
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2022.11368
Subject(s) - blocking (statistics) , pi3k/akt/mtor pathway , oncogene , multiple myeloma , protein kinase b , cancer research , molecular medicine , cell cycle , signal transduction , apoptosis , biology , microbiology and biotechnology , immunology , genetics , computer science , computer network